Abstract
Since its introduction early in the 1980s, magnetic resonance (MR) has become established as the most important paraclinical tool for monitoring treatment efficacy in phase III multiple sclerosis (MS) trials. MR protocols are now routinely incorporated in such studies, providing powerful evidence of therapeutic effect and extending clinical observations.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33: 1444–1452
Noseworthy JH, Vandervoort MK, Wong CJ, et al. (1990) Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology 40:971–975
Rudick RA, Antel J, Confavreux C, et al. (1996) Clinical outcome assessment in multiple sclerosis. Ann Neurol 40: 469–479
Whitaker JN, McFarland HF, Rudge P, et al. (1995) Outcomes assessment in multiple sclerosis clinical trials: A critical analysis. Mult Scler 1: 37–47
Miller DH, Grossman RI, Reingold SC, et al. (1998) The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121: 3–24
Thompson AJ, Kermode AG, Wicks D, et al. (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29: 53–62
Thompson AJ, Miller DH, Youl B, et al. (1992) Serial gadolinium enhanced MRI in relapsing remitting multiple sclerosis of varying disease duration. Neurology 42:60–63
Miller DH, Barkhof F, Nauta JJ (1993) Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116:1077–1094
Kidd D, Thorpe JW, Kendall BE, et al. (1996) MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 60:15–19
Paty DW, Li DKB, Oger JJF, et al. (1994) Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 36: S95–S96
Gass A, Barker GJ, Kidd D, et al. (1994) Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 36: 62–67
IFNB Multiple Sclerosis Study Group, University of British Columbia MS/MRI Analysis Group (1995) Interferon beta-lb in the treatment of multiple sclerosis: Final outcome of the randomised, controlled trial. Neurology 45:1277–1285
Gasperini C, Horsfield MA, Thorpe JW, et al. (1996) Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: Relationship to clinical parameters. J Magn Reson Imaging 6: 580–584
Zhao GJ, Li DKB, Wolinsky JS, et al. (1997) Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis. J Neuroimaging 7: 1–7
McDonald WI (1992) Multiple sclerosis: Diagnostic optimism [editorial]. BMJ: 1256–1260
Allen IV, McKeown SR (1979) A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 41: 81–91
Armspach JP, Gounot D, Rumbach L, et al. (1991) In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magn Reson Imaging 9: 107–113
Dousset V, Grossman RI, Ramer KN, et al. (1992) Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging. Radiology 182:483–491
Filippi M, Campi A, Dousset V, et al. (1995) A magnetisation transfer imaging study of normal appearing white matter in multiple sclerosis. Neurology 45: 478–482
Loevner LA, Grossman RI, Cohen JA, et al. (1995) Microscopic disease in normal-appearing white matter on conventional images in patients with multiple sclerosis: Assessment with magnetization-transfer measurements. Radiology 196:511–515
Arnold DL, Matthews PM, Francis G, et al. (1992) Proton magnetic resonance spectroscopic imaging for metabolic characterisation of demyelinating plaques. Ann Neurol 31: 235–241
Husted CA, Goodkin DS, Hugg JW, et al. (1994) Biochemical alterations in multiple sclerosis lesions and normal appearing white matter demonstrated by in vivo 31P and 1H spectroscopic imaging. Ann Neurol 36:157–165
Rooney WD, Goodkin DE, Schuff N, et al. (1997) 1H MRSI of normal appearing white matter in multiple sclerosis. Mult Scler 3: 231–237
Davie CA, Barker GJ, Thompson AJ, et al. (1997) 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 63: 736–742
Fu L, Matthews PM, De Stefano N, et al. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121:103–113
Barbosa S, Blumhardt LD, Roberts N, et al. (1994) Magnetic resonance relaxation time mapping in multiple sclerosis: Normal appearing white matter and the “invisible” lesion load. Magn Reson Imaging 12: 33–42
Miller DH, Barkhof F, Albert PS, et al. (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of MS. Ann Neurol 39: 6–16
Paty DW, Li DKB, the UBC MS/MRI Study Group, the IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting MS. MRI analysis results of a multcenter, randomised, double blind, placebo controlled trial. Neurology 43: 662–667
Miller DH, Molyneux PD, MacManus DG, et al. (1998) A double-blind, placebo-controlled trial of beta interferon-1b in secondary progressive multiple sclerosis. Neurology (in press)
Polman C, Dahlke F, Thompson AJ, et al. (1995) Interferon beta-1b in secondary progressive multiple sclerosis. Outline of the clinical trial. Mult Scler 1: S51–54
Filippi M, Horsfield MA, Ader HJ, et al. (1998) Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 43: 499–506
Paty DW, Rebif Study Group (1997) Interferon-beta 1A (Rebif) in the treatment of relapsing-remitting multiple sclerosis: The MRI results of a large multicentre study. Mult Scler 3: 269
Molyneux PD, Miller DH, Filippi M, et al. (1998) Sample size requirements for phase III treatment trials based on changes in total brain lesion load on T2 weighted images: A model based approach to power calculations. In: Proceedings of the International Society of Magnetic Resonance in Medicine 2:1320 (abstract)
Cavazzuti M, Merelli E, Tassone G, et al. (1997) Lesion load quantification in serial MR of early relapsing multiple sclerosis patients in azathioprine treatment. A retrospective study. Eur Neurol 38: 284–290
Filippi M, van Waesberghe JH, Horsfield MA, et al. (1997) Interscanner variation in brain MRI lesion load measurements in MS: Implications for clinical trials. Neurology 49: 371–377
Evans AC, Frank JA, Antel J, et al. (1997) The role of MRI in clinical trials of multiple sclerosis: Comparison of image processing techniques. Ann Neurol 41: 125–132
Simon JH, Jacobs LD, Campion M, et al. (1998) Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Ann Neurol 43: 79–87
Rudick RA, Simonian NA, Alam JA, et al. (1998) Incidence and significance of neutralizing antibodies to interferon beta-la in multiple sclerosis. Neurology 50:1266–1272
Tubridy N, Ader HJ, Barkhof F, et al. (1998) Exploratory treatment trials in multiple sclerosis using MRI: Sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups. J Neurol Neurosurg Psychiatry 64: 50–55
Thompson AJ, Kermode AJ, MacManus DG, et al. (1989) Pathogenesis of progressive multiple sclerosis [letter]. Lancet i: 1322–1323
Thompson AJ, Polman C, Miller DH, et al. (1997) Primary progressive multiple sclerosis. Brain 120: 1085–1096
Leary SM, Miller DH, Thompson AJ (1997) Design of a study of interferon beta-la in primary progressive multiple sclerosis. J Neurol 244(Suppl 3): 291
Tofts PS, Barker GJ, Filippi M, et al. (1997) An oblique cylinder contrast-adjusted (OCCA) phantom to measure the accuracy of brain lesion estimation schemes in multiple sclerosis. Magn Reson Imaging 15: 183–192
Gawne-Cain ML, Webb S, Tofts P, et al. (1996) Lesion volume measurement in MS: How important is accurate repositioning? J Magn Reson Imaging 6: 705–713
Simon JH, Scherzinger A, Raff U, et al. (1997) Computerized method of lesion volume quantification in multiple sclerosis: Error of serial studies. AJNR Am J Neuroradiol 18: 580–582
Filippi M, Marcianò N, Capra R, et al. (1997) The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis. Neurology 49: 274–276
Rovaris M, Gawne-Cain ML, Sormani MP, et al. (1998) The effect of repositioning on brain MRI lesion load assessment in multiple sclerosis: Reliability of subjective quality criteria. J Neurol 245: 273–275
Gallagher HL, MacManus DG, Webb SL, et al. (1997) A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis. J Magn Reson Imaging 7: 439–441
Molyneux PD, Tubridy N, Parker GJM, et al. (1998) The effect of slice thickness between 1 and 5 mm with 3D fast-FLAIR on MRI lesion detection and quantification in multiple sclerosis. AJNR Am J Neuroradiol (in press)
Jacobs LD, Cookfair DL, Rudick RA, et al. (1996) Intramuscular interferon beta-la for disease progression in relapsing multiple sclerosis. Ann Neurol 39: 285–294
Kastrukoff LF, Oger JJ, Hashimoto SA, et al. (1990) Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology 40: 479–486
Hennig J, Naureth A, Friedburg H (1986) RARE imaging: A fast imaging method for clinical MR. Magn Reson Med 3: 823–833
Hennig J, Friedburg H (1988) Clinical applications and methodological developments of RARE technique. Magn Reson Imaging 6: 391–395
Bastianello S, Bozzao A, Paolillo A, et al. (1997) Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. AJNR Am J Neuroradiol 18: 699–704
Thorpe JW, Halpin SF, MacManus DG (1994) A comparison between fast and conventional spin-echo in the detection of multiple sclerosis lesions. Neuroradiology 36:388–392
Constable RT, Gore JC (1992) The loss of small objects in variable TE imaging: Implications for FSE, RARE and EPI. Magn Reson Imaging 28: 9–24
Rovaris M, Gawne-Cain ML, Wang L, et al. (1997) A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semiautomated contour technique. Neuroradiology 39: 161–165
Gawne-Cain ML, O’Riordan JI, Coles A, et al. (1998) MRI lesion volume measurement in MS and its correlation with disability: A comparison of fast FLAIR and spin echo sequences. J Neurol Neurosurg Psychiatry 64:197–203
Barkhof F, Filippi M, Miller D, et al. (1997) Strategies for optimising MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J Neurol 244: 76–84
Grossman RI (1996) Magnetic resonance imaging: Current status and strategies for improving multiple sclerosis clinical trial design. In: Goodkin DE, Rudick RA (eds) Treatment of multiple sclerosis: Trial design, results, and future strategies. Springer, Berlin Heidelberg New York, pp 161–186
61. De Coene B, Hajnal JV, Gatehouse P, et al. (1992) MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. AJNR Am J Neuroradiol 13:1555–1564
Thorpe JW, Halpin SF, MacManus, et al. (1994) Detection of multiple sclerosis by magnetic resonance imaging. Lancet 344:1235
De Coene B, Hajnal JV, Pennock JM, et al. (1993) MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. Neuroradiology 35: 327–331
Rydberg JN, Hammond CA, Grimm RC, et al. (1994) Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion recovery pulse sequence. Radiology 193: 173–180
Filippi M, Yousry T, Baratti C, et al. (1996) Quantitative assessment of MRI lesion load in multiple sclerosis: A comparison of conventional spin echo with fast fluid attenuated inversion recovery. Brain 119:1349–55
Gawne-Cain ML, O’Riordan JI, Thompson AJ, et al. (1997) Multiple sclerosis lesion detection in the brain: a comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo. Neurology 49: 364–370
67. Hajnal JV, Oatridge J, Murdoch J, et al. (1998) Failure of FLAIR sequences to suppress CSF in the posterior fossa: Diagnosis of a problem and solution with adiabatic inversion pulses. In: Proceedings of the International Society of Magnetic Resonance in Medicine 2:1350 (abstract)
Boggild MD, Williams R, Haq N, et al. (1996) Cortical plaques visualised by fluid-attenuated inversion recovery imaging in multiple sclerosis. Neuroradiology 38(Suppl 1): 10–13
Filippi M, Horsfield MA, Rovaris M, et al. (1998) Intraobserver and interobserver variability in schemes for estimating volume of brain lesions on MR images in multiple sclerosis. AJNR Am J Neuroradiol 19: 239–244
Gawne-Cain ML, Silver NC, Moseley IF, et al. (1997) Fast FLAIR of the brain: The range of appearances in normal subjects and its application to quantification of white matter disease. Neuroradiology 39: 243–249
Bradley WG, Glenn BJ (1987) The effect of variation in slice thickness and interslice gap on MR lesion detection. AJNR Am J Neuroradiol 8:1057–1062
Filippi M, Horsfield MA, Campi A, et al. (1995) Resolution-dependent estimates of lesion volumes in MRI studies of the brain in multiple sclerosis. Ann Neurol 38: 749–754
Filippi M, Yousry T, Horsfield M, et al. (1996) A high-resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 40: 901–907
Barker GJ (1998) 3D Fast FLAIR. A CSF-nulled fast spin echo pulse sequence. Magn Reson Imaging (in press)
Filippi M, Horsfield MA, Tofts PS, et al. (1995) Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 118:1601–1612
Erickson BJ, Avula RT (1998) An algorithm for automatic segmentation and classification of magnetic resonance brain images. J Digit Imaging 11: 74–82
77. Clarke LP, Velthuizen RP, Camacho MA, et al. (1995) MRI segmentation: Methods and applications. Magn Reson Imaging 13: 343–68
Plante E, Turkstra L (1991) Sources of error in the quantitative analysis of MRI scans. Magn Res Imaging 9: 589–595
Molyneux PD, Wang L, Lai M, et al. (1998) Quantitative techniques for lesion load measurement in multiple sclerosis: An assessment of the global threshold technique after non-uniformity and histogram matching corrections. Eur J Neurol 5: 55–60
Fleiss JL (1985) The design and analysis of clinical experiments. John Wiley and Sons, New York
Streiner DL, Norman GR (1995) Health measurement scales: A practical guide to their development and use. Oxford University, Oxford, pp 104–127
Molyneux PD, Tofts PS, Fletcher A, et al. (1998) Precision and reliability for measurement of MRI lesion volume in multiple sclerosis: A comparison of two computer assisted techniques. J Neurol Neurosurg Psychiatry 65: 42–47
Koopmans RA, Li DKB, Redekop WK, et al. (1993) The use of magnetic resonance imaging in monitoring interferon therapy of multiple sclerosis. J Neuroimaging 3: 163–168
Filippi M, Gawne-Cain ML, Gasperini C, et al. (1998) Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis. Neurology 50: 238–244
Wicks DAG, Tofts PS, Miller DH, et al. (1992) Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study. Neuroradiology 34: 475–479
Filippi M, Rovaris M, Campi A, et al. (1996) Semi-automated thresholding technique for measuring lesion volumes in multiple sclerosis: Effects of change of the threshold on the computed lesion loads. Acta Neurol Scand 93: 30–34
Filippi M, Horsfield MA, Bressi S, et al. (1995) Intra- and inter-observer variability of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques. Brain 118: 1593–1600
Grimaud J, Lai M, Thorpe J, et al. (1996) Quantification of MRI lesion load in MS: a comparison of three computer-assisted techniques. Magn Reson Imaging 14: 495–505
van Walderveen MAA, Barkhof F, Hommes OR, et al. (1995) Correlating MRI and clinical disease: Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 45: 1684–1690
Kohn M, Tanna M, Herman G (1991) Analysis of brain and cerebrospinal fluid volumes with MR imaging. Radiology 178:115–122
Kikinis R, Shenton M, Jolesz F, et al. (1992) Routine quantitative MRI-based analysis of brain and fluid spaces. J Magn Reson Imaging 2: 619–629
Mitchell JR, Karlik SJ, Lee DH, et al. (1994) Computer-assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain. J Magn Reson Imaging 4: 197–208
Simmons A, Arridge SR, Barker GJ, et al. (1994) Improvements in the quality of MRI cluster analysis. Magn Reson Imaging 12: 1191–1204
Simmons A, Arridge SR, Barker GJ, et al. (1996) Simulation of MRI cluster plots and application to neurological segmentation. Magn Reson Imaging 14: 73–92
Bedell BJ, Narayana PA, Wolinsky JS (1997) A dual approach for minimising false lesion classification on magnetic resonance images. Magn Reson Med 37: 94–102
Udupa JK, Samarasekera S (1996) Fuzzy connectedness and object definition: Theory, algorithms and applications in image segmentation. Graph Models Image Proc 58: 246–261
Udupa JK, Wei L, Samarasekera S, Miki Y, et al. (1997) Multiple sclerosis lesion quantification using fuzzy connectedness principles. IEEE Trans Med Imaging 16: 598–609
Samaresekera S, Udupa JK, Miki Y, et al. (1997) A new computer-assisted method for the quantification of enhancing lesions in multiple sclerosis. J Comput Assist Tomogr 21:145–151
Edan G, Miller D, Clanet M, et al. (1997) Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: A randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry 62:112–118
Goodkin DE, Ross JS, Medendorp SM, et al. (1992) MRI lesion enlargement in MS. Disease-related activity, chance occurrence, or measurement artifact? Arch Neurol 49: 261–263
Barkhof F, Filippi M, van Waesberghe JH, et al. (1997) Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology 49: 1682–1688
Molyneux PD, Miller DH, Filippi M, et al. (1998) Intra and inter-observer variation in reporting activity on serial T2 weighted brain MR images in multiple sclerosis. In: Proceedings of the International Society of Magnetic Resonance in Medicine 2:1330 (abstract)
Smith ME, Stone LA, Albert PS, et al. (1993) Clinical worsening in multiple sclerosis is associated with increased number and area of gadopentate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 33: 480–489
Filippi M, Paty DW, Kappos L (1995) Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow-up study. Neurology 45:255–260
Khoury SJ, Guttman CRG, Orav EJ, et al. (1994) Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology 44: 2120–2124
Pozilli C, Bastianello S, Koudriavtseva T, et al. (1996) Magnetic resonance imaging changes with recombinant human interferon-B-la: A short term study in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 61: 251–258
Molyneux PD, Filippi M, Barkhof F, et al. (1998) Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Ann Neurol 43: 332–339
Frank JA, Stone LA, Smith ME, et al. (1994) Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: Implications for treatment trials. Ann Neurol 36(Suppl): S86–S90
Losseff N, Kingsley DPE, McDonald WI, et al. (1996) Clinical and magnetic resonance predictors of disability in primary and secondary progressive multiple sclerosis. Mult Scler 1:218–222
Koudriavtseva T, Thompson AJ, Fiorelli M, et al. (1997) Gadolinium enhanced MRI disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 62: 285–287
Giovannoni G, Lai M, Thorpe J, et al. (1997) Longitudinal study of soluble adhesion molecules in multiple sclerosis: Correlation with gadolinium enhanced magnetic resonance imaging. Neurology 48: 1557–1565
Hiehle JF, Grossman RI, Ramer KN, et al. (1995) Magnetization transfer effects in MR-detected multiple sclerosis lesions: Comparison with gadolinium-enhanced spin echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 16: 69–77
van Waesberghe JHTM, Castelijns JA, Scheltens P, et al. (1997) Comparison of four potential parameters of tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 15: 155–162
Truyen L, van Waesberghe JH, van Walderveen MA, et al. (1996) Accumulation of hypointense lesions (‘black holes’) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47: 1469–1476
van Walderveen MAA, Kamphorst W, Scheltens, et al. (1998) Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 50: 1282–1288
van Waesberghe JHTM, van der Boom R, Filippi M, et al. (1998) MR outcomes in multiple sclerosis. Comparison of conventional parameters and MTR parameters in association with disability. In: Proceedings of the International Society of Magnetic Resonance in Medicine 2: 1319 (abstract)
Lycklama a Nijeholt GJ, van Walderveen MAA, Castelijns JA, et al. (1998) Brain and spinal cord abnormalities in multiple sclerosis. Correlations between MRI parameters, clinical subtypes and symptoms. Brain 121: 687–697
Filippi M, Rocca MA, Horsfield MA, et al. (1998) Increased spatial resolution using a three-dimensional T1-weighted gradient-echo MR sequence results in greater hypointense lesion volumes in multiple sclerosis. AJNR Am J Neuroradiol 19: 235–238
Sailer M, Losseff N, Wang L, et al. (1998) The relationship between T1 lesion load and cerebral atrophy in multiple sclerosis. J Neurol 245(6/7): 371 (abstract)
O’Riordan JI, Gawne-Cain M, Coles A, et al. (1998) T1 hypointense lesion load assessment in secondary progressive multiple sclerosis. J Neurol 245(6/7): 440 (abstract)
van Waesberghe JHTM, van Walderveen MAA, Castelijns JA, et al. (1998) Patterns of lesion development in multiple sclerosis: Longitudinal observations with T1-weighted spin-echo and magnetisation transfer MR. AJNR Am J Neuroradiol 19: 675–683
Wolff SD, Balaban RS (1989) Magnetisation transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 10:135–144
Wolff SD, Balaban RS (1994) Magnetization transfer imaging: Practical aspects and clinical applications. Radiology 192: 593–599
Fralix TA, Ceckler TL, Wolff SD, et al. (1991) Lipid bilayer and water proton magnetization transfer: Effect of cholesterol. Magn Reson Med 18: 214–223
Silver NC, Barker GJ, MacManus, et al. (1996) Decreased magnetisation transfer ratio due to demyelination: A case of central pontine myelinolysis. J Neurol Neurosurg Psychiatry 61: 208–209
Silver NC, Barker GJ, MacManus DG, et al. (1997) Magnetisation transfer ratio of normal brain white matter: A normative database spanning four decades of life. J Neurol Neurosurg Psychiatry 62: 223–228
Lexa FJ, Grossman RI, Rosenquist AC (1994) MR of Wallerian degeneration in the feline visual system: Characterization by magnetization transfer rate with histopathologic correlation. AJNR Am J Neuroradiol 15: 201–212
Dousset V, Brochet B, Vital F, et al. (1994) MR Imaging including diffusion and magnetisation transfer of chronic relapsing experimental encepalomyelitis-correlation with immunological and pathological datas. In: Proceedings of the International Society of Magnetic Resonance in Medicine 2:1401 (abstract)
Dousset V, Brochet B, Vital A, et al. (1995) Lysolecithin-induced demyelination in primates: Preliminary in vivo study with MR and magnetisation transfer. AJNR Am J Neuroradiol 16: 225–231
Thorpe JW, Barker GJ, Jones SJ, et al. (1995) Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and elctrophysiology. J Neurol Neurosurg Psychiatry 59: 487–492
Filippi M, Rocca MA, Rizzo G, et al. (1998) Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium. Neurology 50: 1289–1293
Lai HM, Davie CA, Gass A, et al. (1997) Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J Neurol 244: 308–311
van Buchem MA, McGowan JC, Kolson DL, et al. (1996) Quantitative volumetric magnetisation transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden. Magn Reson Med 36: 632–636
van Buchem MA, Udupa JK, McGowan, et al. (1997) Global volumetric estimation of disease burden in multiple sclerosis based on magnetisation transfer imaging. AJNR Am J Neuroradiol 18:1287–1290
Silver NC, Gass A, Barker GJ, et al. (1998) Evaluation of magnetisation transfer ratio histogram analysis methods in multiple sclerosis. In: Proceedings of the International Society of Magnetic Resonance in Medicine 2: 1322 (abstract)
Iannucci G, Rovaris M, Minicucci L, et al. (1998) Assessment of disease severity in multiple sclerosis patients with magnetisation transfer histograms. In: Proceeding of the International Society of Magnetic Resonance in Medicine 1: 120 (abstract)
Berry I, Barker G, Barkhof F, et al. (1996) A multicenter measurement of magnetisation transfer ratio in normal white matter. In: Proceedings of the International Society of Magnetic Resonance in Medicine 1: 536 (abstract)
Barker GJ, Schreiber W, Gass A, et al. (1997) Standardising magnetisation transfer ratio measurements between MR scanners from different manufacturers. In: Proceedings of the International Society of Magnetic Resonance in Medicine 3: 1556 (abstract)
Kidd D, Thorpe JW, Thompson AJ, et al. (1993) Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43: 2632–2637
Thorpe JW, Kidd D, Moseley IF, et al. (1996) Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46: 373–378
Thorpe JW, Kidd D, Moseley IF, et al. (1996) Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 119: 709–714
Filippi M, Campi A, Colombo B, et al. (1996) A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 243: 502–505
Losseff NA, Webb SL, O’Riordan JI, et al. (1996) Spinal cord atrophy and disability in multiple sclerosis: A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119: 701–708
Losseff NA, Stevenson VL, Miller DH, et al. (1996) Spinal cord atrophy and disability in multiple sclerosis: A serial MRI study. Eur J Neurol 3(Suppl 4): 2 (abstract)
Stevenson VL, Leary SM, Losseff NA, et al. (1998) Spinal cord atrophy and disability in multiple sclerosis: A longitudinal study. Neurology (in press)
Silver NC, Barker GJ, Losseff NA, et al. (1997) Magnetisation transfer ratio measurement in the cervical spinal cord: A preliminary study in multiple sclerosis. Neuroradiology 39: 441–445
Mathias JM, Tofts PS, Losseff NA (1998) Quantification of pathological changes within the spinal cord due to multiple sclerosis (MS) using texture analysis. In: Proceedings of the International Society of Magnetic Resonance in Medicine 2:1336 (abstract)
Losseff NA, Wang L, Lai HM, et al. (1996) Progressive cerebral atrophy in multiple sclerosis. A serial study. Brain 119: 2009–2019
Fox NC, Freeborough PA (1997) Brain atrophy progression measured from registered serial MRI: Validation and application to Alzheimer’s disease. J Magn Reson Imaging 7: 1069–1075
Mastronardo G, Rocca MA, Comi G, et al. (1998) Quantitative volumetric analysis of brain MRI from patients with multiple sclerosis. In: Proceedings of the International Society of Magnetic Resonance in Medicine 2:1315 (abstract)
Arnold DL, Matthews PM, Francis G, et al. (1990) Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease. Magn Reson Med 14: 154–159
Davie CA, Barker GJ, Webb S, et al. (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118:1583–1592
Davie CA, Hawkins CP, Barker GJ, et al. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117: 49–58
De Stefano N, Matthews PM, Antel JP, et al. (1995) Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 38: 901–909
Narayana PA, Doyle TJ, Lai D, et al. (1998) Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 43: 56–71
Larsson HBW, Christianson P, Jenson M, et al. (1991) Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med 22: 23–31
Grossman RI, Lenkinski RE, Ramer KN, et al. (1992) MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 13: 1535–1543
Kidd D, Barker GJ, Tofts PS, et al. (1997) The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosis. J Neurol 244:125–130
Horsfield MA, Lai M, Webb SL, et al. (1996) Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med 36: 393–400
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Italia
About this paper
Cite this paper
Molyneux, P.D., Miller, D.H. (1999). Magnetic Resonance Imaging Techniques to Monitor Phase III Treatment Trials. In: Filippi, M., Grossman, R.I., Comi, G. (eds) Magnetic Resonance Techniques in Clinical Trials in Multiple Sclerosis. Topics in Neuroscience. Springer, Milano. https://doi.org/10.1007/978-88-470-2153-2_5
Download citation
DOI: https://doi.org/10.1007/978-88-470-2153-2_5
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2180-8
Online ISBN: 978-88-470-2153-2
eBook Packages: Springer Book Archive